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The Hong Kong Mental Morbidity Survey: 
Background and Study Design
香港精神健康調查：背景和研究設計
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Cheung, PC Sham, HFK Chiu, M Lam, TP Chiang, J van Os, JTF Lau, G Lewis, P Bebbington; The 
Hong Kong Mental Morbidity Survey Team
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Abstract
Mental disorders are highly prevalent conditions with immense disease burden. To inform health 
and social services policy formulation, local psychiatric epidemiological data are required. The Hong 
Kong Mental Morbidity Survey is a 3-year population-based study in which 5700 community-dwelling 
Chinese adults aged between 16 and 75 years were interviewed with the aim of evaluating the prevalence, 
co-morbidity, functional impairment, physical morbidity, and social determinants of significant mental 
disorders in the population. This paper describes the background and design of the survey, and is the first 
territory-wide psychiatric epidemiological study in Hong Kong.
Key words: Asian continental ancestry group; Health surveys; Mental disorders / epidemiology
摘要
精神障礙非常普遍，且對社會造成巨大的疾病負擔。收集本地精神病流行病學資料，對計劃相
關的衛生及社會服務政策至為重要。香港精神健康調查是一個為期3年，以人口為基礎的大型研
究，透過對5700名介乎16歲至75歲之華裔市民進行精神健康評估，檢視重要的精神障礙的現
患率、共病、功能障礙、身體疾病以及社會決定因素。本文闡述這項首個全港大型精神病流行
病研究的背景和設計。
關鍵詞：亞洲大陸血統群、健康調查、精神障礙／流行病學
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Rising Burden of Mental Disorders
Globally, mental disorders have emerged as an important 
health care challenge. It is well documented that people 
with severe mental illnesses (SMI) such as schizophrenia 
are associated with significant disability if appropriate 
treatment is not provided.1 Patients with SMI also suffer 
from increased morbidity and mortality.2,3 They are more 
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of fully structured diagnostic interviews like Diagnostic 
Interview Schedule (DIS),14 Composite International 
Diagnostic Interview (CIDI),15 and Revised Clinical 
Interview Schedule (CIS-R)16 have made ascertainment of 
psychiatric diagnoses by trained lay interviewers possible. 
The refinement of community survey methodologies also 
contributes to the growth in the number of international 
large-scale psychiatric epidemiology studies in recent years.
 One of the most notable examples is the Adult 
Psychiatric Morbidity Survey (APMS) conducted in the 
UK in 1993, 2000, and 2007. In the latest APMS,17 multi-
stage stratified probability sampling design was used and 
a representative population of more than 7000 adults aged 
≥ 16 years residing in private households in England was 
interviewed. The survey adopted a 2-phase design. In 
Phase 1, CIS-R was administered to generate an overall 
score and diagnosed 6 types of CMD. A sub-sample of 
participants interviewed in Phase 1 was further interviewed 
in Phase 2, when psychiatric disorders, like psychosis, were 
assessed. In addition to estimating the prevalence of various 
psychiatric conditions, APMS in 2007 also examined the 
trends in psychiatric morbidity by comparing the data with 
those from studies performed in 1993 and 2000.
Prevalence of Mental Disorders in Hong Kong
Evidence shows that the prevalence of mental disorders is not 
uniform across the globe. The World Health Organization’s 
World Mental Health Survey Initiative,18 one of the largest 
cross-national epidemiological surveys so far, estimated 
the prevalence of mental disorders in 17 countries across 
Europe, America, Africa, Middle East, and Asia. The survey 
found that the prevalence of mental disorders varied widely 
across countries. The lifetime prevalence of any anxiety 
disorder ranged from 4.8 to 31.0% in different parts of the 
world. The prevalence of mood disorder (3.3-21.4%), any 
impulse control disorder (0.3-25.0%), and any substance 
use disorder (1.3-15.0%) also differed widely. Therefore, 
assumptions about the prevalence of mental disorders in 
Hong Kong based on overseas data may not be appropriate.
 While it is essential to have local epidemiological 
information, there is a paucity of updated psychiatric 
prevalence data in Hong Kong. To date, the only large-
scale community survey is the Shatin Community Mental 
Health Survey conducted by Chen et al19 between 1984 
and 1986. A total of 7229 respondents residing in Shatin 
were interviewed. In Phase 1, they were screened with 
Self-Reporting Questionnaire, and DIS version III was 
adopted to establish psychiatric diagnosis in Phase 2. The 
commonest DSM-III diagnoses were tobacco dependence 
(male vs. female, 26.56% vs. 1.43%), generalised anxiety 
disorder (7.77% vs. 11.11%), alcohol abuse / dependence 
(8.86% vs. 0.62%), all phobias (1.28% vs. 3.73%), and 
dysthymic disorder (1.25% vs. 2.83%). 
 Since the completion of Shatin Survey,19 there have 
been important changes in diagnostic nomenclature in 
mental health. The DSM-III criteria were replaced by 
vulnerable than the general population to nutritional and 
metabolic diseases, cardiovascular diseases, viral diseases, 
respiratory tract diseases, musculoskeletal diseases, sexual 
dysfunction, pregnancy complications, stomatognathic 
diseases, and possibly, obesity-related cancers.3 The average 
life expectancy of people with SMI is 25 years shorter than 
that of the general population.2
 Adverse health and social outcomes are not limited 
to SMI. Common mental disorders (CMD) like anxiety 
disorders and depressive disorders also lead to significant 
personal, social, and economic loss. Evidence shows that 
these conditions are associated with significant psychosocial 
disability,4 functional impairment, loss of productivity,5,6 
and poor quality of life.7,8 Patients with CMD also have 
considerably increased risk of mortality. In a recent meta-
analysis of 10 prospective cohort studies involving 68,222 
adults living in England, participants experiencing anxiety 
or depression had a shorter life expectancy than the general 
population.9 The association between psychological distress 
and mortality demonstrated a strong dose-response effect.9 
The increased risk in mortality persisted after adjusting for 
age, gender, alcohol consumption, smoking, and social class.
 Overall, mental disorders constitute one of the major 
causes of disease burden worldwide. Neuropsychiatric 
disorders explain 13.5% of disability-adjusted life years 
(DALYs), thus surpassing the burden due to cancer 
and cardiovascular disease.10 In the latest estimation of 
worldwide disease burden, which measured DALYs for 291 
causes in 187 countries, the global DALYs were found to be 
reduced by 0.5% over the past 20 years. However, DALYs 
caused by mental and behavioural disorders have increased 
by 37.6%.11 Of all the mental disorders, depressive disorders 
accounted for 2.5% of DALYs, followed by anxiety disorders 
(1.1%), drug-use disorders (0.8%), alcohol-use disorders 
(0.7%), and schizophrenia (0.6%).11 It is estimated that the 
disease burden caused by mental disorders will continue to 
rise, and unipolar depressive disorders will emerge as the 
non-communicable disease leading to the greatest DALYs 
by 2030.12
Psychiatric Epidemiology
Considering the immense burden associated with 
mental disorders, there is a rising need for psychiatric 
epidemiological data. Large-scale community studies of 
mental morbidity provide valuable information for effective 
policy formulation, health and social services planning, 
generating hypotheses, and monitoring disease trends.13 
 Traditionally, the prevalence of mental disorders was 
estimated from a number of sources, such as psychiatric 
hospital admission and attendance data, local case registers, 
statistics of consultations in general practice, and local 
community surveys.13 However, these sources are often 
bound by methodological limitations, making the data less 
generalisable to areas that were not surveyed. The past 
few decades have seen a revolution in how psychiatric 
epidemiological surveys were conducted. The development 
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DSM-IV then DSM-5, and ICD-9 criteria by ICD-10. These 
were accompanied by the development of corresponding 
diagnostic instruments such as CIS-R and CIDI, and 
advancement in the psychiatric epidemiological research 
methodology. In addition, socio-demographic characteristics 
of the local population have changed significantly over the 
past 30 years.20 The population of Hong Kong has been 
rapidly increasing (total population of 4.99 million in 1981 
to 7.07 million in 2011) and ageing (median age from 26.0 
years in 1981 to 41.7 years in 2011).20 Gender distribution 
has also changed remarkably since 1980. In 1981, 52.2% 
of the local population comprised men, which dropped 
to 46.7% in 2011.20 The participants residing in Shatin 
back in the 1980s are, therefore, very different from the 
local population nowadays. Furthermore, substance abuse 
practices in Hong Kong have also changed significantly 
over the past few decades. According to the latest Central 
Registry of Drug Abuse report,21 the number of abusers 
taking psychotropic substances is higher than that using 
traditional drugs or opiates since 2007. Besides, ketamine, 
the most commonly abused psychotropic substance today, 
was virtually unheard of in the 1980s. These data warrant 
an updated and territory-wide community survey of mental 
disorders in Hong Kong. 
Hong Kong Mental Morbidity Survey
Objectives
The Hong Kong Mental Morbidity Survey (HKMMS) is 
a 3-year project funded by the Food and Health Bureau 
(FHB) of Hong Kong SAR Government. It commenced in 
2010 and was completed in 2013. It was proposed by local 
researchers and mental health specialists from The Chinese 
University of Hong Kong, The University of Hong Kong, 
Kwai Chung Hospital, Castle Peak Hospital, and Kowloon 
Hospital, and experts from the UK and the Netherlands with 
the aim of achieving the following objectives:
1. to estimate the prevalence of significant mental 
disorders among community-dwelling Chinese adults 
in Hong Kong;
2. to estimate the functional impairment associated with 
significant mental disorders;
3. to identify the relationship between significant mental 
disorders and social factors;
4. to identify the relationship between significant mental 
disorders and physical morbidity; 
5. to evaluate the extent and nature of service use in 
relation to significant mental disorders; 
6. to characterise psychosis risk states and the associated 
risk factors in a community sample;
7. to study co-morbidity between significant mental 
disorders; and
8. to collect information on potential protective factors for 
mental wellbeing.
Study Design
In preparing for the present study, methodologies for 
epidemiological survey of mental morbidity were reviewed. 
There were 2 standard designs which involved either a 
single- or 2-phase approach. The current study adopted 
the 2-phase design represented by the APMS. Three 
APMSs have been conducted to evaluate the psychiatric 
morbidity among adults living in private households in 
the UK (1993, 2000, and 2007).17 An alternative, but much 
more costly single-phase approach was represented by 
a series of studies employing the CIDI,18 which is a fully 
structured interview schedule designed for use by trained 
lay interviewers. This instrument assesses a broad spectrum 
of mental disorders according to the ICD-10 and DSM-IV 
criteria. The studies employing CIDI assume elaborative 
single-phase methodology yielding information covering 
a wide array of psychiatric diagnoses; but substantial 
financial, technical, and professional support is required 
for single-phase assessment. The APMS assumes a more 
focused and less costly approach addressing only specific 
mental disorders which have significant impact on service 
planning. Considering the resource implications and specific 
aims of the proposal of HKMMS, the research team referred 
to the methodology of the APMS performed in England in 
2007.
Study Population and Recruitment
The study population of HKMMS consists of 5700 Chinese 
adults aged between 16 and 75 years, representative of 
community-dwelling population in Hong Kong. This 
sample size was chosen as it is large enough to enable us 
to look into the means and 95% confidence intervals for 
prevalence of CMD, psychotic experience, substance22 
and alcohol misuse, as well as suicidal behaviours in 
related epidemiological surveys (Table 1).17,23 Sample size 
estimates for CMD were derived by referring to the more 
prevalent anxiety and depressive disorders. The sample 
size for psychotic experience was calculated based on 
the prevalence of psychotic symptoms (at-risk mental 
states) reported in APMS.17 We also acknowledged biases 
of under-reporting in community surveys and gender 
differences in substance misusers. For suicidal behaviours, 
sample size estimates were derived from 1-year prevalence 
data of suicide attempts from surveys conducted in England 
and Hong Kong. Sample size requirements for the above 4 
conditions were estimated separately. We decided to adopt 
the estimate for 1-year prevalence data of suicide attempt 
for the overall requirement for this study.
 With the assistance of the Census and Statistics 
Department of the Hong Kong SAR Government, a multi-
stage sampling design was used. The sampling frame 
consisted of randomly selected addresses, which were 
stratified according to geographical districts and the nature 
of premises. This multi-stage stratification first followed the 
distribution of residential premises in different geographical 
districts, and the relative proportion of private versus public 
housing units. Samples of geographical areas representative 
of the residential distribution in Hong Kong were selected, 
followed by subsequent stages of geographical sampling 
Hong Kong Mental Morbidity Survey
East Asian Arch Psychiatry 2014, Vol 24, No.1 33
the closest birthday criteria. For subjects who were willing 
to participate, but were unavailable or unable to provide 
full information (e.g. intellectual disability or sensory 
impairments), proxy information from first-degree relatives 
was obtained and the data were specified as proxy. It is 
recognised that the mental health population survey should 
include community-dwelling citizens of different ethnicities. 
The HKMMS aimed to provide basic information about 
global mental health status of the Hong Kong community. 
After the current study, it is envisaged that the protocol and 
assessment materials will be adapted for an extension study 
including non-Chinese participants in Hong Kong.  
 At least 3 letters were sent in advance to each 
household until responses were obtained. For households 
which declined to participate, the address was counted as 
refusal with no substitution allowed. For addresses where 
residence were not eligible or addresses where home visits 
(e.g. estates within districts, blocks within estates, 
households within blocks). 
 Invitation letters were sent to each selected address, 
in advance, to introduce the survey. At least 1 on-site visit 
was conducted to addresses where entry to the building 
was allowed to seek permission for interview. A telephone 
hotline was established to address queries and refusals. 
Only 1 adult per household was invited to participate to 
reduce the inter-dependency of the observations due to 
clusters of mental disorders that might run in families. 
To avoid introduction of any bias, the household member 
with birthday closest to the day of interview was selected 
for assessment. Inclusion criteria included age between 
16 and 75 years inclusive, Chinese ethnicity, birthday 
closest to the date of first selected interview, and consent 
for participation. Exclusion criteria were age < 16 years or 
> 75 years, non-Chinese ethnicity, and non-satisfaction of 
Table 1. References for estimation of sample sizes.
Figure.  Flowchart of Assessment Schedule for the Hong Kong Mental Morbidity Survey
Address quarters drawn randomly 
from the Census and Statistics 
Department of Hong Kong SAR 
Government
Phase 1
5700 Participants invited for home 
interviews (1 person per household)
Phase 2a
Participants with positive psychotic 
screen who agreed for second 
interviews
Phase 2b
A random sample of participants 
with self-harm ideas (n = 70) versus 
control (n = 70)
Phase 2c
2% of Phase 1 participants without 
Revised Clinical Interview Schedule 
diagnoses were reassessed by 
clinicians for specificity (n = 114)
Adult Psychiatric Morbidity 
Survey in England17 China survey (urban cities)
23
Prevalence 
(95% confidence 
interval)
Sample size 
estimates
Prevalence (95% confidence 
interval)
Sample size estimates
Common mental 
disorders
16.5 (15.2-17.2) 
Mixed anxiety and 
depressive disorder: 
6.9 (6.0-7.9)
2401 
2661
Mood disorders: 5.66 (4.80-6.68) 
Anxiety disorders: 6.86 (5.42-8.65)
Mood disorders: 2717 
Anxiety disorders: 921
Positive 
psychotic screen
4 4268 -
Alcohol misuse 24.2 (23.0-25.4) 1668 5.24 (4.15-6.59) 1614
One-year 
suicidal attempts
5.6 (5.0-6.3) 5683 -
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were not permitted with undetermined eligibility, another 
address from the same area and housing type was generated 
as a replacement.
Field Work
Before commencement of HKMMS, preparatory studies 
were performed to validate the instruments in the local 
population. Phase 1 of HKMMS estimated the community 
prevalence of CMD, and the associated risk factors and 
impacts. In this phase, participants were interviewed 
with a structured interview schedule serving diagnostic 
criteria for CMD, and screening instruments for psychotic 
disorders, substance misuse, and suicidal behaviours. 
The demographic data were recorded, and the everyday 
functioning, 1-year service utilisation for mental health 
problems, and associated risk factors were evaluated. Phase 
1 interviews were conducted by trained research assistants. 
 The second phase of HKMMS comprised 3 studies 
conducted by clinicians. Phase 2a and Phase 2b studies were 
targeted at conditions of special significance to public health 
and early interventional efforts. Phase 2a study measured 
the prevalence of psychotic disorders and psychosis risk 
states (well-defined at-risk states for developing psychosis). 
Optimal management of psychotic disorders is a core 
priority for the public mental health services. Information 
from this study will be critical for the development of 
early detection and preventive intervention efforts. Phase 
2b study measured self-harm ideations and behaviour, and 
the relationship of these with other mental health disorders 
and risk factors. Such information will be important to 
formulate a range of preventative and interventional 
strategies to contain suicide rates in the population. In 
addition, 2% of the participants who were screened negative 
at Phase 1 were invited to take part in Phase 2c study. They 
were interviewed with Structured Clinical Interview for the 
DSM-IV (SCID) by psychiatrists to check the specificity 
of Phase 1 diagnostic instruments. The Figure depicts an 
overview of the assessment schedule for the HKMMS.
Interview Schedules
Assessment instruments adopted at different phases of 
HKMMS are listed in Table 2.
Phase 1 Studies
Instruments for Phase 1 study consisted of the following:
1. Questionnaires on basic demographic information, 
general health and wellbeing, physical illness checklist, 
social support, and health service use for the past year. 
In addition, participants’ psychosocial functioning was 
evaluated with Social and Occupational Functioning 
Assessment Scale, an assessment from the DSM-IV-
TR of an individual’s level of social and occupational 
functioning.24 This instrument considers social and 
occupational functioning on a continuum from 
excellent functioning to grossly impaired functioning. 
It evaluates impairments in functioning due to physical 
limitations as well as mental disorders. In addition, the 
presence of life events was assessed with Life Event 
Checklist, a 17-item checklist of exposure to stressful 
life events and has been demonstrated to correlate with 
psychological distress.25
2. Common mental disorders were diagnosed with 
CIS-R16 which is a structured psychiatric assessment 
interview schedule tapping non-psychotic symptoms in 
the week prior to interview. It consists of 14 symptom 
group sections including somatic symptoms, fatigue, 
concentration and forgetfulness, sleep problems, 
irritability, worry about physical health, depression, 
depressive ideas, worry, anxiety, phobias, panic, 
compulsions, and obsessions. The sum of the key 
area scores generates a total score, a measure of non-
psychotic psychiatric morbidity. The symptom clusters 
and scores were amalgamated to form ICD-10 diagnoses 
of 6 groups of CMD including generalised anxiety 
disorders, mixed anxiety and depressive disorder, 
depressive episode, phobias, obsessive-compulsive 
disorder, and panic disorder. 
3. Psychosis Screening Questionnaire (PSQ) assessed 
psychotic symptoms in the past year. It has 5 probe 
questions (plus secondary questions) enquiring about 
mania, thought insertion, paranoia, strange experiences, 
and hallucinations.26
Table 2. Assessment instruments included in Hong Kong 
Mental Morbidity Survey.
Phase 1
1. Basic demographic information
2. 12-Item Short-Form Health Survey
3. Cumulative Illness Rating Scale
4. Life Event Checklist
5. Multidimensional Scale of Perceived Social Support
6. Social and Occupational Functioning Assessment 
Scale
7. Service use for mental health problems in the past 
year
8. Revised Clinical Interview Schedule
9. Psychosis Screening Questionnaire
10. Beck Scale for Suicide Ideation
11. Beck Hopelessness Scale
12. Questionnaire on substance misuse and dependence
13. Alcohol Use Disorders Identification Test
14. Community version of the Severity of Alcohol 
Dependence Questionnaire
Phase 2a
1. Structured Clinical Interview for the DSM-IV
2. Comprehensive Assessment of At-Risk Mental State
Phase 2b
1. The External Entrapment and Defeat Scale
2. The Life Events and Difficulties Schedule
3. The Means-End Problem Solving Tasks
4. The Impact of Events Scale
5. Depressive Rumination Scale
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4. Suicidal ideas and behaviours were evaluated by 
the Beck Scale for Suicide Ideation (BSS),27 Beck 
Hopelessness Scale,28 and questions listed in the CIS-R. 
5. Drug misuse and dependence was assessed by a 
questionnaire on substance misuse and dependence. 
Besides, alcohol misuse was assessed by Alcohol Use 
Disorders Identification Test29 and Community version 
of the Severity of Alcohol Dependence Questionnaire 
(SADQ-C).30 The former evaluates hazardous drinking; 
it takes into consideration the year before the interview 
as a reference period, consists of 10 items, and covers 
areas including hazardous alcohol consumption, 
harmful alcohol consumption, and symptoms of 
dependence. The other instrument, SADQ-C, is 
developed specifically for use in the general population. 
It is composed of 20 items, covering a range of 
dependence symptoms, with the 6 months before the 
interview as the reference period. 
Phase 2 Studies
Instruments for Phase 2 study consisted of the following:
1. Phase 2a: Phase 1 participants who were screened 
positive with PSQ were assessed by psychiatrists 
with the Hong Kong Chinese version of SCID31,32 to 
establish psychiatric diagnoses. In addition, they were 
interviewed by Comprehensive Assessment of At-Risk 
Mental States,33 which identifies participants with an 
ultra-high risk of transition to psychosis.
2. Phase 2b: A randomly selected sample of Phase 1 
interviewees (n = 70) with a score of 1 or 2 in item 
4 (desire to make active suicide attempt) or item 
5 (passive suicidal desire) of the BSS (cases) was 
recruited into the Phase 2b of the study. A control group 
(n = 70) comprising subjects who scored 0 in item 4 
or item 5 of the BSS were selected from the survey 
participants. To identify the psychosocial risk factors 
of suicidal ideas and behaviours, they were interviewed 
with the External Entrapment and Defeat Scale,34 
Life Events and Difficulties Schedule,35 Means-End 
Problem Solving Tasks,36 Impact of Events Scale,37 and 
Depressive Rumination Scale.38
3. Phase 2c: 2% of the participants who were screened 
negative were invited for a SCID interview by 
psychiatrists to check the specificity of Phase 1 
diagnostic instruments.
Conclusion
Modelling after overseas psychiatric epidemiological 
studies, HKMMS is the first territory-wide study in Hong 
Kong designed to examine the prevalence of mental 
disorders in a representative sample of the local population. 
It also evaluates functional and physical morbidity, social 
factors associated with mental disorders, and assesses 
co-morbidity and service utilisation patterns. In addition, 
psychosis risk states and potential protective factors for 
mental wellbeing were examined. The results of this study 
will be submitted to the FHB of the Hong Kong SAR 
Government and published as a series of scientific papers. 
We believe that findings of the HKMMS will have important 
implications for mental health policy formulation, health 
and social care manpower planning, as well as medical, 
nursing, and allied health professional education in Hong 
Kong. Understanding the epidemiological data pertaining 
to the most significant and most common mental disorders, 
their respective risk factors and at-risk states will also 
facilitate planning of early detection and interventional 
services and future preventive strategies. To monitor the 
mental health status of the Hong Kong community, the 
HKMMS should be repeated at regular intervals so that 
service plans can be revised according to the changing 
needs of the population. 
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